Further studies in bm12-induced lupus and MRL/lpr spontaneous lupus with two structurally related Ezh2 selective small molecule inhibitors, GSK503 and GSK126, respectively, demonstrated significantly reduced autoAb production, GC formation, and improved lupus nephritis [27,28]. Here, EZH2 is linked to systemic lupus erythematosus.